synthetic estrogen selective agonist shows selectivity transactivation erα erβ values nm erα weaker estradiol nm erβ weaker however another found potency transactivation erα drug antagonistic activity either induced prostate cancer development preclinical models given combination testosterone whereas testosterone alone contrast selective erβ agonist protective development prostate cancer produced two findings suggest opposing roles erα erβ prostate chemical structure appear disclosed drug article relating genitourinary system stub help wikipedia expanding